HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells

[1]  K. Tracey,et al.  Endogenous HMGB1 regulates autophagy , 2010, The Journal of cell biology.

[2]  K. Tracey,et al.  HMGB1 Release and Redox Regulates Autophagy and Apoptosis in Cancer Cells , 2010, Oncogene.

[3]  N. Mizushima,et al.  Methods in Mammalian Autophagy Research , 2010, Cell.

[4]  S. Kimura,et al.  Blockade of the ERK or PI3K-Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib. , 2010, Biochemical and biophysical research communications.

[5]  M. Lotze,et al.  The Receptor for Advanced Glycation End-products (RAGE) Sustains Autophagy and Limits Apoptosis, Promoting Pancreatic Tumor Cell Survival , 2009, Cell Death and Differentiation.

[6]  T. Ochiya.  [Novel mechanisms of drug resistance in cancer]. , 2010, Seikagaku. The Journal of Japanese Biochemical Society.

[7]  Herbert J Zeh,et al.  High-mobility group box 1 and cancer. , 2010, Biochimica et biophysica acta.

[8]  Y. Yu,et al.  WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells , 2010, Leukemia.

[9]  M. Lotze,et al.  Autophagy inhibition in combination cancer treatment. , 2009, Current opinion in investigational drugs.

[10]  M. Lotze,et al.  Ethyl pyruvate administration inhibits hepatic tumor growth , 2009, Journal of leukocyte biology.

[11]  E. White,et al.  The Double-Edged Sword of Autophagy Modulation in Cancer , 2009, Clinical Cancer Research.

[12]  Ashutosh Kumar Singh,et al.  A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy via Regulating Beclin 1* , 2009, The Journal of Biological Chemistry.

[13]  D. Stroncek,et al.  Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer , 2009, Journal of Translational Medicine.

[14]  M. Dyer,et al.  Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. , 2009, The Journal of clinical investigation.

[15]  Haichao Wang,et al.  Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. , 2009, American journal of respiratory cell and molecular biology.

[16]  H. Vihinen,et al.  Monitoring autophagy by electron microscopy in Mammalian cells. , 2009, Methods in enzymology.

[17]  P. Rovere-Querini,et al.  HMGB1: a two-headed signal regulating tumor progression and immunity. , 2008, Current opinion in immunology.

[18]  Ying Zhao,et al.  Vitamin D3 Induces Autophagy of Human Myeloid Leukemia Cells* , 2008, Journal of Biological Chemistry.

[19]  Shan Zhu,et al.  [Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.

[20]  D. Tang,et al.  [Enhancive effect of HMGB1 gene silence on adriamycin-induced apoptosis in K562/A02 drug resistance leukemia cells]. , 2008, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[21]  A. Apel,et al.  Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. , 2008, Cancer research.

[22]  A. Basu,et al.  Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-α-induced cell death in MCF-7 cells , 2008, Journal of cellular and molecular medicine.

[23]  John L Cleveland,et al.  Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. , 2008, The Journal of clinical investigation.

[24]  Haichao Wang,et al.  A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis* , 2008, Critical care medicine.

[25]  L. Riboni,et al.  HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration , 2008, Journal of Neuro-Oncology.

[26]  L. Zitvogel,et al.  The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy , 2007, Immunological reviews.

[27]  M. Omata,et al.  Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. , 2007, Biochemical and biophysical research communications.

[28]  G. Bjørkøy,et al.  p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy* , 2007, Journal of Biological Chemistry.

[29]  Haichao Wang,et al.  The Anti-inflammatory Effects of Heat Shock Protein 72 Involve Inhibition of High-Mobility-Group Box 1 Release and Proinflammatory Function in Macrophages1 , 2007, The Journal of Immunology.

[30]  J. Cleveland,et al.  Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. , 2007, Blood.

[31]  Haichao Wang,et al.  Nuclear Heat Shock Protein 72 as a Negative Regulator of Oxidative Stress (Hydrogen Peroxide)-Induced HMGB1 Cytoplasmic Translocation and Release1 , 2007, The Journal of Immunology.

[32]  D. Tang,et al.  [High mobility group box 1 is increased in children with acute lymphocytic leukemia and stimulates the release of tumor necrosis factor-alpha in leukemic cell]. , 2007, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[33]  Haichao Wang,et al.  Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.

[34]  D. Pisetsky,et al.  The extracellular release of HMGB1 during apoptotic cell death. , 2006, American journal of physiology. Cell physiology.

[35]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[36]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[37]  Raymond Sawaya,et al.  The role of autophagy in cancer development and response to therapy , 2005, Nature Reviews Cancer.

[38]  A. Ramos,et al.  Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. , 2005, Blood.

[39]  D. Tang,et al.  HEAT SHOCK RESPONSE INHIBITS RELEASE OF HIGH MOBILITY GROUP BOX 1 PROTEIN INDUCED BY ENDOTOXIN IN MURINE MACROPHAGES , 2005, Shock.

[40]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[41]  D. Clapham,et al.  Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization , 2004, The Journal of Neuroscience.

[42]  L. Young,et al.  Inhibition of Phosphatidylinositol 3-Kinase- and ERK MAPK-regulated Protein Synthesis Reveals the Pro-apoptotic Properties of CD40 Ligation in Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[43]  J. McCubrey,et al.  The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia , 2002, Leukemia.

[44]  E. Estey,et al.  Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. , 2001, The Journal of clinical investigation.

[45]  Y. Ohsumi,et al.  Beclin–phosphatidylinositol 3‐kinase complex functions at the trans‐Golgi network , 2001, EMBO reports.

[46]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[47]  D. Ross,et al.  Novel mechanisms of drug resistance in leukemia , 2000, Leukemia.

[48]  P. Codogno,et al.  Distinct Classes of Phosphatidylinositol 3′-Kinases Are Involved in Signaling Pathways That Control Macroautophagy in HT-29 Cells* , 2000, The Journal of Biological Chemistry.